Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial
- DOI
- 10.1200/jco-25-00131
- Published
- 2025-06-20
- Container
- Journal of Clinical Oncology
- Publisher
- American Society of Clinical Oncology (ASCO)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1200/jco-25-00131,
title = {Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial},
author = {Jarey H. Wang and Alexander D. Sherry and Soha Bazyar and Philip Sutera and Noura Radwan and Ryan M. Phillips and Matthew P. Deek and Jiayun Lu and Shirl Dipasquale and Curtiland Deville and Theodore L. DeWeese and Daniel Y. Song and Hao Wang and Robert F. Hobbs and Reem Malek and Sara A. Dudley and Stephen C. Greco and Emmanuel S. Antonarakis and Catherine H. Marshall and Samuel Denmeade and Channing J. Paller and Michael A. Carducci and Kenneth J. Pienta and Orhan K. Oz and Matthew Ramotar and James L. Leenstra and Sean S. Park and Matthew C. Abramowitz and Neil Desai and Alejandro Berlin and Bradley J. Stish and Chad Tang and Phuoc T. Tran and Ana P. Kiess},
year = {2025},
journal = {Journal of Clinical Oncology},
doi = {10.1200/jco-25-00131},
url = {https://doi.org/10.1200/jco-25-00131}
}RIS
TY - JOUR TI - Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial AU - Jarey H. Wang AU - Alexander D. Sherry AU - Soha Bazyar AU - Philip Sutera AU - Noura Radwan AU - Ryan M. Phillips AU - Matthew P. Deek AU - Jiayun Lu AU - Shirl Dipasquale AU - Curtiland Deville AU - Theodore L. DeWeese AU - Daniel Y. Song AU - Hao Wang AU - Robert F. Hobbs AU - Reem Malek AU - Sara A. Dudley AU - Stephen C. Greco AU - Emmanuel S. Antonarakis AU - Catherine H. Marshall AU - Samuel Denmeade AU - Channing J. Paller AU - Michael A. Carducci AU - Kenneth J. Pienta AU - Orhan K. Oz AU - Matthew Ramotar AU - James L. Leenstra AU - Sean S. Park AU - Matthew C. Abramowitz AU - Neil Desai AU - Alejandro Berlin AU - Bradley J. Stish AU - Chad Tang AU - Phuoc T. Tran AU - Ana P. Kiess PY - 2025 JO - Journal of Clinical Oncology DO - 10.1200/jco-25-00131 UR - https://doi.org/10.1200/jco-25-00131 ER -
APA
Wang, J. H., Sherry, A. D., Bazyar, S., Sutera, P., Radwan, N., Phillips, R. M., Deek, M. P., Lu, J., Dipasquale, S., Deville, C., DeWeese, T. L., Song, D. Y., Wang, H., Hobbs, R. F., Malek, R., Dudley, S. A., Greco, S. C., Antonarakis, E. S., Marshall, C. H., Denmeade, S., Paller, C. J., Carducci, M. A., Pienta, K. J., Oz, O. K., Ramotar, M., Leenstra, J. L., Park, S. S., Abramowitz, M. C., Desai, N., Berlin, A., Stish, B. J., Tang, C., Tran, P. T., & Kiess, A. P. (2025). Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-00131
Source records
- crossref · retrieved 2026-09-26T08:35:39.897Z